An evaluation of 6 placebo-controlled scientific trials with one,134 complete members concluded that cannabinoids (nabiximols, dronabinol, and THC/CBD) were connected to a higher normal improvement about the Ashworth scale for spasticity in multiple sclerosis sufferers compared with placebo, Though this didn't reach statistical significance.We view… Read More